Axitinib
Brand name: Inlyta
Axitinib comes in 4 pill versions in our database, in 2 strengths, from 2 manufacturers. Check the imprint to tell them apart.
Axitinib pill images
1 mg 2 pills
- Pfizer 1 XNB Axitinib 1 mg Red, oval, 9 mm Used for renal cell carcinoma
- Pfizer 1 XNB Axitinib 1 mg Red, oval Used for renal cell carcinoma
5 mg 2 pills
What is Axitinib used for?
Axitinib is used for renal cell carcinoma.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
First-Line Advanced Renal Cell Carcinoma
INLYTA in combination with avelumab is indicated for the first-line treatment of patients with advanced renal cell carcinoma (RCC).
INLYTA in combination with pembrolizumab is indicated for the first-line treatment of patients with advanced RCC.
Second-Line Advanced Renal Cell Carcinoma
INLYTA as a single agent is indicated for the treatment of advanced RCC after failure of one prior systemic therapy.
From the FDA-approved label on DailyMed (published Mar 16, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.